About The Company

stock-photo-7986125-happy-family-vt

We are a biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. 

We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.  We are developing Vigil®, our proprietary immunotherapy platform in multiple advanced cancer indications with the lead program for the treatment of patients with advanced ovarian cancer.

Leadership Team

Board Of Directors

News & Events